| 1. |
|
|
| 2. |
|
|
| 3. |
- Mann, B. S., et al.
(författare)
-
High temperature friction and wear characteristics of various coating materials for steam valve spindle application
- 2000
-
Ingår i: Wear. - 0043-1648 .- 1873-2577. ; 240:1-2, s. 223-230
-
Tidskriftsartikel (refereegranskat)abstract
- Various coatings such as chromium carbide (deposited by plasma spraying and detonation gun techniques), chromium oxide, chromium oxide + titania + silica, NiCrAlY, and Al2O3 + Ni all deposited by plasma spraying; stelliting, and surface nitriding have been applied on X20CrMo V121 steel. This steel is used for high temperature applications such as steam turbine valve spindle. Friction and wear behavior of the surface coated and treated materials have been studied at an elevated temperature of 550°C while rubbing against graphite-filled stellited steel. These studies have been carried out on SRV optimol reciprocating tribometer. Test parameters for tribological studies have been selected with a view to simulate operating conditions encountered in operation. Additionally, the structure, porosity, hardness, bond strength, and thermal cycling behaviour of these surface coated/treated materials have been characterised. Based on these laboratory investigations, chromium carbide coating deposited by plasma spraying technique has been identified as the most suitable coating for steam turbine valve spindle application. Process parameters have been established for deposition of chromium carbide coating by plasma spraying technique on actual valve spindles. The field results obtained are found to be commensurate with the laboratory findings.
|
|
| 4. |
|
|
| 5. |
|
|
| 6. |
- Weinreb, Neal J, et al.
(författare)
-
Gaucher disease type 1 : revised recommendations on evaluations and monitoring for adult patients.
- 2004
-
Ingår i: Semin Hematol. - 0037-1963. ; 41:4 Suppl 5, s. 15-22
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
- For patients with type 1 Gaucher disease, challenges to patient care posed by clinical heterogeneity, variable progression rates, and potential permanent disability that can result from untreated or suboptimally treated hematologic, skeletal, and visceral organ involvement dictate a need for comprehensive, serial monitoring. An updated consensus on minimum recommendations for effective monitoring of all adult patients with type 1 Gaucher disease has been developed by the International Collaborative Gaucher Group (ICGG) Registry coordinators. These recommendations provide a schedule for comprehensive and reproducible evaluation and monitoring of all clinically relevant aspects of this disease. The initial assessment should include confirmation of deficiency of beta-glucocerebrosidase, genotyping, and a complete family medical history. Other assessments to be performed initially and at regular intervals include a complete physical examination, patient-reported quality of life using the SF-36 survey, and assessment of hematologic (hemoglobin and platelet count), visceral, and skeletal involvement, and biomarkers. Specific radiologic imaging techniques are recommended for evaluating visceral and skeletal pathology. All patients should undergo comprehensive regular assessment, the frequency of which depends on treatment status and whether therapeutic goals have been achieved. Additionally, reassessment should be performed whenever enzyme therapy dose is altered, or in case of significant clinical complication.
|
|
